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In this study we provide the first in vivo evidences showing that, under physiological conditions, “tissue” transglutaminase (TG2) might acts as
a protein disulphide isomerase (PDI) and through this activity contributes to the correct assembly of the respiratory chain complexes.Mice lacking
TG2 exhibit mitochondrial energy production impairment, evidenced by decreased ATP levels after physical challenge. This defect is
phenotypically reflected in a dramatic decrease of motor behaviour of the animals. We propose that the molecular mechanism, underlying such a
phenotype, resides in a defective disulphide bonds formation in ATP synthase (complex V), NADH-ubiquinone oxidoreductase (complex I),
succinate-ubiquinone oxidoreductase (complex II) and cytochrome c oxidase (complex IV). In addition, TG2-PDI might control the respiratory
chain by modulating the formation of the prohibitin complexes. These data elucidate a new pathway that directly links the TG2-PDI enzymatic
activity with the regulation of mitochondrial respiratory chain function.
© 2006 Elsevier B.V. All rights reserved.Keywords: Respiratory chain complex; ATP synthase; HSP60; Prohibitin; Transglutaminase 2 knock out mice; Protein Disulphide Isomerase1. Introduction
Transglutaminases (TGases) are a family of calcium
dependent cross-linking enzymes involved in post-translational
modification of proteins. TGases catalyse intra- and inter-
molecular isodipeptide bonds, between the γ-carboxiamide
groups of glutamine residues and primary amino groups of
several compounds. Different isoforms with diverse tissue
distribution are known [1,2]. The most ubiquitous isoenzyme is
represented by type 2 transglutaminase (TG2), a versatile
multifunctional protein involved in a variety of biochemical
functions. In the presence of high calcium levels, TG2 catalyses
protein–protein cross-linking as well as incorporation of
primary amine into proteins [3]. It is well known that TG2⁎ Corresponding author. Department of Biology, University of Rome “Tor
Vergata”, Via della Ricerca Scientifica 00133 Rome, Italy. Tel.: +39 672594234;
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doi:10.1016/j.bbabio.2006.07.007possesses other functions than the Ca2+ dependent cross-
linking activity; in fact, it can act as a G-protein, coupling
adrenoreceptors, thromboxane and oxytocine receptors to
phospholipase C (PLCδ1). This activity is inhibited by Ca2+,
which acts as a switch between the two enzyme's main
functions [4]. Recently, on the basis of in vitro observations, a
novel Ca2+-independent disulphide isomerase activity has been
hypothesized for the enzyme [5]. In the past years, TG2 has
been widely related to programmed cell death, being
selectively expressed during apoptosis [6]. Its ectopic over-
expression increases the levels of apoptosis in various cell
lines, conversely, its silencing leads to a decrease in cell death
levels [7]. The deregulation of enzyme activity, generally is
associated with major disruptions in cellular/tissue homeostasis
and results in the enzyme contributing to a number of human
diseases such as coeliac disease, neurodegeneration, maturity
onset diabetes and tissue fibrosis/scarring [3]. TG2 gene
deletion as well as chemical inhibition of its enzymatic activity
improves symptoms as well as life spanning in Huntington's
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disease has been recently proposed [9]. Although the involve-
ment of TG2 in a number of pathologies has been well
documented, its role in normal physiological conditions is still
obscure. TG2 knock-out (TG2−/−) mice are viable, fertile and
without any evident developmental abnormality [10]. Recently,
it has been shown that TG2−/− mice have impaired glucose-
stimulated insulin secretion and thus intolerance after glucose
loading, with a phenotype resembling that of maturity-onset
diabetes of young (MODY), thus suggesting a physiological
role for TG2 in glucose tolerance [11]. Defects in glucose-
induced insulin release have been widely related to defective
respiratory chain activation and loss of ATP production [12]. In
keeping with these findings we previously showed that TG2
co-localize with mitochondria and that its over-expression
leads to mitochondrial hyper-polarization [13]. Moreover,
recently we demonstrated that ablation of TG2 causes an
impairment in the balance between complex I and complex II
of the mitochondrial respiratory chain, demonstrating a
physiological role for TG2 in mitochondrial respiratory
complexes homeostasis [14]. On the basis of these evidences,
we decided to further investigate the mitochondrial function-
ality in TG2−/− mice. In this paper, we demonstrate for the first
time, that TG2 might act in vivo as a protein disulphide
isomerase (PDI) and through this activity it contributes to the
mitochondrial respiratory complexes disulphide levels. We
show that TG2 ablation causes impairment in ATP production
resulting in a decreased spontaneous locomotor activity. Taken
together, these results provide a molecular basis for a novel in
vivo function for this enzyme, thus indicating that a protein
involved in programmed cell death might have alternative roles
in the regulation of cell homeostasis in living cells.
2. Materials and methods
All reagents, unless otherwise indicated, were purchased from SIGMA.
2.1. Animals
All animals were housed and farmed according to the guidelines proposed
by the Italian National Research Council. Animals were sacrificed through
cervical dislocation.
2.2. Antibodies
Antibodies against respiratory complexes proteins were purchased from
Molecular Probes. The used dilutions were respectively: complex I 39 kDa
subunit and 17 kDa subunit 0.5 μg/ml; complex II 70 kDa subunit 0.1 μg/ml and
30 kDa subunit 5 μg/ml; complex III core 1 (51.6 kDa) 0.1 μg/ml and core 2
(48.5 kDa) 0.4 μg/ml; complex IV 57 kDa subunit 2 μg/ml and 20 kDa subunit
0.2 μg/ml; complex V subunit α (59.8 kDa) 0.5 μg/ml and subunit β (56.6 kDa)
0.2 μg/ml. Anti-prohibitin antibody was purchased from NeoMarkers and
dilution used was 0.2 μg/ml. Anti-Hsp60 antibody was purchased from
Stressgen and dilution used was 1:10000.
2.3. Identification of TG2 substrates
TG2 over-expressing cells (TGA) were grown as previously described [13]
in the presence of 5 mM TGase labelling substrate 5-(biotinamido)pentylamine
(EZ-link, Pierce) and 1 μm staurosporine (STS) for 3 h.Biotinylated TG2 substrates were purified by affinity using streptavidin
magnetic beads following manufacturer's protocol (Promega). Briefly, magnetic
beads were incubated with cellular lysate and after extensive washing in PBS,
suspended in SDS-PAGE loading buffer. Purified proteins were dissociated from
the beads by boiling the solution for 10 min a 95 °C. Purified proteins were
separated through standard SDS-PAGE.
2.4. Behavioural assay
Spontaneous locomotor activity was measured in a computer-controlled
apparatus consisting of eight toggle-floor boxes, each one divided into two
compartments (20×10 cm) connected by a 3×3 cm opening, as previously
described [15]. For each mouse the number of crossings from one compartment
to the other, by means of a micro-switch connected to the tilting floor of the box,
was recorded for 60 min. Scores of consecutive 10-min periods were calculated.
The apparatus was located in a sound-insulated cubicle. All values are expressed
as means±SEM.
2.5. Blue native electrophoresis
Complexes were solubilised according to a modified protocol of Schagger
and von Jagow [16]. Briefly, mitochondrial pellet was suspended in 8 volumes
of buffer (750 mM aminocaproic acid, 50 mM Bis-Tris, protease inhibitor
cocktail (Roche) and 1 volume of 10% laurylmaltoside. The mixture was
subsequently centrifuged at 100000×g for 15 min. The supernatant contains
solubilised mitochondrial complexes. Blue Native electrophoresis was
performed on a Protean II Xi cell (Bio-Rad). The 5%–13% polyacrilamide
gradient gels in aminocaproic acid were prepared as described. Electrophoresis
was led at 4 °C and 75 V until proteins entered the stacking gel and, then, the
cathode buffer containing G250 Coomassie Blue (Serva) was replaced by a
buffer without the dye. Electrophoresis was continued over night at 150 V. Gels
were stained with G250 Coomassie over night.
2.6. Western blot analysis
Tissues were collected immediately after sacrifice and homogenised in
sucrose 250 mM, Tris–HCl pH 7.4 20 mM, EDTA 1 mM and protease inhibitors
(Complete, EDTA free, ROCHE). Mitochondria were isolated as previously
described [17]. Proteins were quantified with standard Bradford staining. 20 μg
of proteins were separated on 5–12% Nu-PAGE (Invitrogen) and transferred to
nitrocellulose membrane. Membranes were probed with the above-described
antibodies and the signals were detected with Supersignal (Pierce).
2.7. Measurement of ATP levels
Adenosine 5′-triphosphate (ATP) levels were measured on liver, brain and
skeletal muscle from wild type and knock out mice, by means of the ATP
Bioluminescent Assay Kit (Sigma), according to manufacturer's indications.
Each sample was mixed with 100 μl of reaction buffer, vortexed briefly, and
light output was measured immediately in a luminometer (Tuner TD). A
standard curve raging from 10−14 to 10−7 moles of ATP has been performed prior
to each experiment.
2.8. Statistical analysis
All the data reported are the mean of at least four different experiments.
Using Student's t-test performed statistic analysis, only p-values of less than
0,01 were considered as significant.3. Results
3.1. TG2 knockout mice exhibit mitochondrial defects
We have previously shown that TG2 protein levels correlate
with alterations of mitochondrial membrane potential (Δψ) and
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polarization. This effect might be due to enhanced proton
pumping by mitochondrial respiratory complexes and, interest-
ingly, is present not only in cells undergoing apoptosis, when
TG2 activity drastically increases, but also in steady state
physiological conditions, when TG2 activity as well as Ca2+
levels are rather low [13]. We hypothesize that, apart its
complex role in cell death [3,18], in physiological conditions
TG2 might participate to mitochondrial homeostasis. Moreover,
these evidences suggested to us that the absence of TG2 might
results in alterations of the respiratory chains that should have
consequences on the global production of ATP in tissues. If this
is the case, such a difference should be more evident and
highlighted, by a prolonged physical challenge, in those organs,
which are not predominantly glycolytic, while should be not
relevant in resting conditions, where ATP reserves are not
depleted. To verify this hypothesis, we compared ATP content
in WT versus TG2−/− mice in resting condition as well as after a
prolonged physical activity. In particular, we analysed the liver,
whose metabolism widely relies on glycolysis and the skeletal
and the cardiac muscles, where mitochondrial phosphorylative
oxidation is, mainly, in charge of ATP production. We failed to
detect any major difference in all tissues analysed under resting
condition (data not shown). On the contrary, after prolonged
physical effort (mice were kept running on Rota Rod at constant
low speed and after 10 min the speed was progressivelyFig. 1. Measurement of ATP levels in tissues from wild type and TG2−/−mice after pr
tissue with pronounced glycolytic activity, while major differences are detectable
mitochondrial activity. TG2−/− animals exhibit a reduced general activity and motility
still active while TG2−/− animals are definitively resting.increased until the mice fall down), the ATP content in skeletal
and cardiac muscle from TG2−/− mice was drastically depleted.
In particular, in the heart, where an utmost severity was found,
we observed about 40% of ATP loss, when compared to
controls (Fig. 1a–c).
These findings support the hypothesis that TG2−/− animals
should exhibit a phenotype as a direct consequence of
mitochondrial defects. To verify this hypothesis we mon-
itored the animal's general activity and indeed we found that
the spontaneous locomotor activity was significantly lowered
in KO versus WT mice. ANOVA analysis of repeated
measures demonstrated a significant main effect for genotype
(F(1,85)=10.495; p<0.01), time (F(5,85)=68.318; p<0.001)
and genotype× time interaction (F(5,85)=5.240; p<0.001)
(Fig. 1d).
3.2. BN-PAGE does not reveal differences in TG2 knockout
animals
On the basis of these evidences we decided to analyse the
mitochondrial respiratory complexes (OXPHOS) in TG2−/−
animals by means of Blue Native electrophoresis, a technique
that allows to separate complexes from mitochondria in their
native state [16]. Fig. 2a shows, considering the detection limits
of the technique, minor differences in the electrophoretic
properties of complexes II, III and V between TG2−/− mice andolonged physical challenge (a, b, c). ATP levels are comparable in the liver (a), a
in skeletal muscle (b) and heart (c), where ATP production is mainly due to
(d). Monitoring of the mice motility shows that after 50 min, wild type mice are
Fig. 2. Analysis of mitochondrial respiratory complexes through blue native electrophoresis (BN-PAGE). (a) The first dimension native electrophoresis, which
separates the whole complexes from isolated mitochondria, failed to reveal any difference between TG2−/− and controls. Bands excised from the first dimension gel
were subjected to a second dimension electrophoresis under reducing conditions onto 4–12% Nu-PAGE. (b) The pattern of bands does not reveal any major difference
between TG2−/− animals and controls, thus indicating that respiratory complexes from TG2−/− mice do not exhibit differences in term of protein composition. (c) The
pattern of bands shows differences between wild-type and TG2−/−mice when second dimension is performed under non reducing conditions, with complexes derived
from TG2−/−mice lack some high molecular weight bands (arrows). In order to confirm the differences observed in the gel run under non reducing conditions, we have
normalised the amount of the 120 kDa band of the complexes V, III and IV by comparing the intensity with that several other bands present in the same gel run under
reducing conditions. We did not detect any significant variations in the bands present in the TG2 KO vs. the WTmice, namely the band ranging at 120 kDa in complex
V has an intensity of 12% less compared to WT; the band of complex III has an intensity of 7% more than the WT and the band present in complex IVan intensity of
15% less than WT. By contrast , as shown in panel c, under non reducing conditions the bands identified with the arrows practically disappear in the TG2 KO mice.
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of protein composition, in each single complex, we performed a
second dimension electrophoresis in reducing conditions (Fig.
2b) but also this approach does not reveal any major appreciable
difference. We concluded that, although the level and the quality
of the respiratory complexes are not significatively affected,
TG2 gene ablation might results in some changes at the post-
translational level.
3.3. TG2 acts as a disulphide isomerase in vivo
TG2 is a multifunctional enzyme and intracellular levels of
calcium and GTP strictly regulate its cross-linking activity. Our
experimental settings, being merely a physiological state, doesnot allow the activation of the cross-linking activity of TG2, so
we decided to investigate possible alternative molecular
mechanisms underlying our findings. A recent report, based
exclusively on in vitro evidences, suggests that, in the presence
of low calcium levels, purified TG2 is able to catalyse the
formation of disulphide bonds [5]. In order to evaluate whether
TG2 might function as a disulphide isomerase in vivo we
analysed the formation of disulphides in mitochondrial
respiratory complexes by means of non-reducing SDS-electro-
phoresis of the BN-PAGE. Fig. 2c shows how some of the high
molecular weight bands present in complexes belonging to wild
type mice mitochondria disappear in TG2−/− ones. On the
contrary, the pattern of bands under reducing conditions is
identical (compare Fig. 2b and c). These findings were also
Fig. 3. Characterization of prohibitin as a TG2 PDI substrate. Isolated
mitochondria were analysed through SDS-PAGE either under reducing and
non reducing condition (in presence or not of β-mercaptoethanol) and probed
with specific antibodies for prohibitin (a) and Hsp60 (b). In wild type mice and
under non reducing conditions prohibitin exhibits a high molecular weight
product, which disappears if reductants are added, suggesting that it is an
oligomer containing disulphides (a, lanes 3, 4). This high molecular weight
product is almost undetectable in the absence of TG2, thus indicating that the
enzyme takes part in the formation of the disulphides bonds in vivo (a, lanes 1,
2). Conversely, Hsp60, another mitochondrial chaperone, it is not modified
through TG2 mediated disulphide bonds formation (b).
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by densitometric analysis. Being β-mercaptoethanol the only
variable introduced here, it is reasonable to think that the
absence of disulphide bonds is responsible for the detected
variations. In keeping with the above reported data, demonstrat-
ing that functionality of complex V and ATP synthesis is
impaired in TG2−/− mice, we show that this complex as well as
other complexes (I and III) have major variations in disulphide
bonds when TG2 is depleted. In keeping with these findings, we
measured complex I activity on heart mitochondria isolated
from wild type and knock out mice. We found a 30–35%
reduction (5.5±0.18 nmol NADHox/mg protein wt vs. 3.93±
0.49 nmol NADHox/mg protein KO) in the activity of complex
I NADH-ubiquinone oxidoreductase in heart's mitochondria
from TG2−/− mice as compared to WT mice.
3.4. Identification of TG2 substrates in mitochondria
Although TG2 is considered mainly a cytosolic protein, there
are several evidences showing that the enzyme may also display
a mitochondrial localization [13,19]. In addition, even TG2
substrates co-localize with mitochondria [14], suggesting that
lack of TG2-mediated post-translational modification in some
mitochondrial proteins could determine the mitochondrial
defect previously described in TG2 knock-out mice.
In order to identify which proteins are substrates of the TG2/
PDI activity we analysed a number of mitochondrial respiratory
chain complex components as well as chaperone proteins
known to play a role in mitochondrial OXPHOS protein import
and assembly [20–22]. We recently demonstrated that Hsp60
and prohibitin act as substrates for TG2 cross-linking activity
[14]. We performed western blot analyses of proteins belonging
to mitochondria isolated from both wild type and TG2−/− mice
tissues, under reducing and non-reducing conditions. Under
reducing conditions, as far as prohibitin is concerned, the levels
of the monomeric protein are comparable in both TG2−/− and
wild type mice (Fig. 3a, lanes 2, 4). Interestingly, under non-
reducing conditions, when disulphide bonds are preserved,
mitochondria from mice lacking TG2 exhibit a drastic reduction
in the levels of the high molecular weight products (Fig. 3a,
lanes 1,3), clearly indicating a direct in vivo correlation between
disulphide bonds formation and the presence of TG2. Moreover,
in wild type animals, the amount of the 30 kDa band,
corresponding to the monomeric form of the protein, is lower
under non reducing as compared to reducing conditions
(compare lanes 3 and 4). These observations suggest that in
the heart, in a physiological context, a relevant part of prohibitin
is present in high molecular weight complexes assembled
through TG2-mediated disulphide bonds. Conversely, the other
chaperone analysed, Hsp60, is not modified by the TG2
isomerase activity (Fig. 3b).
Prompted by these results, we then investigated whether
other intrinsic protein components of the respiratory complexes
are modified by the TG2/PDI activity. Protein from mitochon-
dria belonging to WT and TG2−/− mice, were analysed by
means of antibodies directed against 10 different components of
the five respiratory chain complexes. As shown in Fig. 4, someof them are largely modified in TG2−/− mice, whereas others are
not affected, thus indicating a high specificity in the TG2/PDI
action. It is interesting to note the difference in the assembly of
the ATP-synthase β-subunit, which is an important component
of the complex V, which is responsible for the ATP synthesis.
To further address whether being a TG2 substrate for the
isomerase activity implies the necessity of being a substrate for
the cross-linking one, we investigated whether proteins, which
show TG2 dependent modification in disulphides, are also
substrates for the cross-linking activity. To this aim, we used
TG2 over-expressing neuroblastoma cells, undergoing apoptosis
in response to staurosporine treatment, coupled to the labelling
of TG2 protein substrates with a biotinylated penthylamine (EZ-
Link) [23]. This compounds enters living cells and acts as a tag,
being cross-linked to glutamine donor substrates by TG2,
allowing purification of labelled substrates [24]. Purified
mitochondrial protein substrates were analysed by western blot
with streptavidin-HRP and specific antibodies for those proteins,
which exhibit variations in disulphide contents. As shown in Fig.
5, although both the analysed proteins are substrates for the
isomerase activity, the 39 kDa subunit of complex I is not a
substrate for the cross-linking reaction. These findings, together
with the evidence about HSP60 [14], which is, vice versa,
substrate for the cross-linking activity but not for the isomerase
one, indicate that these two enzymatic activities are unrelated.
4. Discussion
The data reported in this study provide the first in vivo
evidence for the existence of a novel TG2 activity, namely
Protein Disulphide Isomerase, and showed that through this
Fig. 4. Several subunits from different mitochondrial complexes are modified through TG2/PDI activity. Purified mitochondria from wild-type and TG2−/− mice were
analysed under reducing and non reducing conditions, through western blot with antibodies directed towards different sub-units of the respiratory complexes. As far as
complex I (a) and complex II (b) are concerned, all the analysed subunits are modified by TG2/PDI. Conversely, any of the studied subunits of complex III (c) is
modified and in complex IV (d), only the 20 kDa subunit is modified. In complex V only the beta-subunit of ATP synthase acts as TG2/PDI substrate.
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functions. In fact, we observed that disulphide bonds content of
mitochondrial respiratory complexes is altered in mice lacking
TG2. This phenomenon leads to a failure in the ATP production,
which is phenotypically reflected in a dramatic decrease of
general motility of these animals. Although a protein disulphide
isomerase activity was reported to be associated with a cross-
linking activity in an ERp60-like protein from the filarial parasite
D. immitis [25] and this evidence was confirmed in vitro by usingpurified mammalian TG2 [5], no proof of the existence of such
an activity as well as its relevance under physiological settings in
vertebrates in vivo was reported so far for any TGases. Our data
indicate that TG2 plays a physiological role as part of the folding
machinery that controls the assembly of the respiratory
complexes in mitochondria, in particular under stressful
conditions. We demonstrated that the structure of some of the
essential elements (see later) of the complex I, II and V are
affected in TG2−/− mice. This study was prompted by our
Fig. 5. TG2/PDI versus cross-linking activity substrates specificity. TG2 over-expressing cells were grown in the presence of the substrate pentylamine–pentylamine
(EZ-link, PIERCE), with or without staurosporine. Biotinylated substrates from isolated mitochondria were purified through streptavidin affinity pull-down
(Streptavidin MagneSphere, Promega) and analysed through western blot with peroxidase conjugated streptavidin (a) or using specific antibody (b, c). Membranes
were probed with specific antibodies to the 70 kDa subunit of complex II (b) and the 39 kDa subunit of complex I (c) which are both substrates for the isomerase
reaction (Fig. 4). Interestingly, only the 70 kDa subunit of complex II acts as a substrate for the cross-linking reaction, while the 39 kDa subunit of complex I is not.
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total cellular TG2 is localized on mitochondria, where it may
affect both the ultra-structural and redox features of the
organelle [13]. We have recently characterized prohibitin,
HSP60 and ATP synthase beta chain as mitochondrial TG2
protein substrates, by using a neural cell line constitutively over-
expressing the enzyme [14]. Interestingly, these two proteins are
widely involved in the correct assembly and function of the
mitochondrial proteins, with particular regard to the respiratory
chains protein components [21]. In particular, prohibitin acts as
a membrane bound chaperone and it has been shown to be
essential for the correct folding of the mitochondrial membrane
proteins [21]. HSP60, together with its essential partner protein
mtHsp70, forms a membrane-associated import motor complex
responsible for vectorial polypeptide movement and unfolding
of pre-protein domains. For some substrate proteins, the
protected folding environment, provided by the large oligomeric
Hsp60 complex, further facilitates the folding reactions [22]. In
addition we detected that, under non reducing conditions, the
electrophoretic features of a major component of the complex V,
the ATP synthase beta chain, results to be modified in absence of
TG2. Although this finding might seem misleading, since the
ATP synthase beta chain does not have any cysteine residue, it
must be noticed that a number of reports show that this protein
behaves as it has cysteine in its primary sequence and has been
identified in various instances as a cysteine containing enzyme
[26].
TG2 is a widely distributed peculiar enzyme that catalyses
the post-translational modification of proteins by the formation
of isopeptide bonds. This may occur through protein–protein
cross-linking, via epsilon-(gamma-glutamyl)lysine bonds, or
through incorporation of primary amines in peptide-bound
glutamine residues. The cross-linked proteins are oligomeric
products, highly resistant to mechanical challenge and proteo-
lytic degradation and their accumulation is specifically found ina number of pathological settings associated with cellular stress
and/or death. The Ca2+ is the essential activator of this
transamidating activity, with the main binding site located at
the terminal α-helix (H4) in domain 2 [2]. Although some
potential regulatory mechanisms (interaction of TG2 with
lysophosphatidylcholine, nitrosylation of the active site cysteine
277) suggest how the enzyme might acquires some activity at
near physiological levels of Ca2+, up to now, it is generally
assumed that under physiological conditions TG2 is largely
inactive as cross-linking enzyme. In keeping with this
assumption, we did not find any oligomerization of the putative
mitochondrial protein partners in living cells and only at a very
little extent in dying ones. Interestingly, TG2/PDI folding
activity does not require high calcium levels and then may occur
under steady state physiological conditions [5]. By studying the
status of several essential components of the respiratory chain
complexes, under native versus reducing conditions, we found
that the observed phenotype for TG2−/− mice might be probably
due to an improper post-translational modification of the
17 kDa and 39 kDa subunits of NADH–ubiquinone oxidor-
eductase (complex I), the 30 kDa and 70 kDa subunit of
succinate–ubiquinone oxidoreductase (complex II) and 20 kDa
subunit of cytochrome c oxidase (complex IV). In fact, western
blot analysis of these proteins under non-reducing conditions,
revealed an evident impairment in the extent of TG2-mediated
disulphide bond formation. The TG2/PDI activity appears to be
very specific, as clearly indicated by the fact that only a fraction
of the analysed proteins were affected in TG2−/− mice. In
particular, the reduced efficiency in ATP synthesis is associated
with lack of disulphide bonds only on the beta-chain of ATP
synthase. Defects observed in TG2−/− mice could be due both to
a direct action of TG2 on the reported proteins as well as to the
absence of TG2-catalysed post-translational modification of the
important chaperone prohibitin. Prohibitins, in eukaryotes,
consist of two subunits that form a high molecular weight
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The evolutionary conservation and the ubiquitous expression in
mammalian tissues of the prohibitin complex suggest an
important function among eukaryotes and the high molecular
weight prohibitin complex has been shown to play an essential
role in the stabilization of newly synthesized subunits of
mitochondrial respiratory enzymes [27].
The observed defects in the correct assembly of mitochon-
drial respiratory complexes result in a reduced ability to
synthesize ATP (particularly under stressful conditions) and a
consequent adult phenotype in TG2−/− mice. Although these
mice do not exhibit major embryonic anomalies, it is important
to note that the energetic supplies during embryonic life are
largely provided by maternal tissues, as demonstrated by the
fact that, even in the most severe human mitochondrial diseases,
death generally occurs in early post-natal life. However, adult
TG2−/− mice show profound differences in behaviour, reflected
in a drastic reduced motorial activity. Moreover, these animals
showed a profound ATP debt, following physical challenge,
mainly in non glycolytic tissues. Interestingly, even the defect in
insulin secretion (MODY) previously observed in these animals
could be, at least in part, explained by the mitochondrial
assembly defects described here, being this pathology also
related to ATP defects [12]. In line with this consideration the
TG2−/− mice represent a very interesting model to study human
pathologies characterized by a defect in the assembly of mito-
chondrial protein complexes.
In conclusion, despite extensive investigations, the questions
of the physiological role played by TG2 and the relevance of the
post-translational modifications of its protein substrates are
open questions. In this study we present compelling evidences,
indicating that the enzyme may act as a Protein Disulphide
Isomerase. The physiological PDI activity described in this
study is well complemented by the transamidating TG2 activity.
Under stressful circumstances, such as those induced by many
cell death stimuli, the increase of intracellular calcium con-
centration switches on TG2 cross-linking activity and determi-
nates the active involvement of the enzyme in apoptosis as
previously reported [3]. Thus, TG2 represents another example
of a cell death-associated protein able to play different functions
according to different cellular context and needs [28]. In
addition this study demonstrated, in vivo, the importance of
disulphide bonds formation in the correct assembly of the
mitochondrial respiratory chain complexes and consequently in
the energy production pathways in the eukaryotic cell.
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